<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>treatment selection Archives - Gateway Psychiatric</title>
	<atom:link href="https://www.gatewaypsychiatric.com/tag/treatment-selection/feed/" rel="self" type="application/rss+xml" />
	<link></link>
	<description>Excellent Psychiatric Care</description>
	<lastBuildDate>Tue, 06 Jul 2021 21:43:13 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://i0.wp.com/www.gatewaypsychiatric.com/wp-content/uploads/2013/06/favicon2.png?fit=32%2C32&#038;ssl=1</url>
	<title>treatment selection Archives - Gateway Psychiatric</title>
	<link></link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">70562394</site>	<item>
		<title>Limbic and Prefrontal Connectivity and Treatment Selection for Depression</title>
		<link>https://www.gatewaypsychiatric.com/limbic-and-prefrontal-connectivity-and-treatment-selection-for-depression/</link>
		
		<dc:creator><![CDATA[Peter Forster]]></dc:creator>
		<pubDate>Thu, 27 Aug 2020 02:00:00 +0000</pubDate>
				<category><![CDATA[Basic Science]]></category>
		<category><![CDATA[Best Practices]]></category>
		<category><![CDATA[Major Depression]]></category>
		<category><![CDATA[Psychobiology]]></category>
		<category><![CDATA[Treatments of Depression]]></category>
		<category><![CDATA[antidepressant]]></category>
		<category><![CDATA[antidepressants]]></category>
		<category><![CDATA[cognitive behavioral therapy]]></category>
		<category><![CDATA[functional brain imaging]]></category>
		<category><![CDATA[outcomes]]></category>
		<category><![CDATA[prediction]]></category>
		<category><![CDATA[subcallosal cingulate cortex]]></category>
		<category><![CDATA[treatment selection]]></category>
		<guid isPermaLink="false">https://www.gatewaypsychiatric.com/?p=12607</guid>

					<description><![CDATA[<p>Boadie Dunlop, M.D., M.S., and Helen Mayberg, M.D., both of Emory University School of Medicine, and colleagues assessed resting-state functional connectivity between the subcallosal cingulate cortex (SCC) and three other brain regions—the dorsal midbrain, the ventrolateral prefrontal cortex and anterior insula, and the ventromedial prefrontal cortex—in 122 patients with depression. The patients were then randomized to 12 weeks of cognitive-behavioral ... </p>
<div><a href="https://www.gatewaypsychiatric.com/limbic-and-prefrontal-connectivity-and-treatment-selection-for-depression/" class="more-link">Read More</a></div>
<p>The post <a href="https://www.gatewaypsychiatric.com/limbic-and-prefrontal-connectivity-and-treatment-selection-for-depression/">Limbic and Prefrontal Connectivity and Treatment Selection for Depression</a> appeared first on <a href="https://www.gatewaypsychiatric.com">Gateway Psychiatric</a>.</p>
]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">12607</post-id>	</item>
		<item>
		<title>Predicting Lithium Response</title>
		<link>https://www.gatewaypsychiatric.com/predicting-lithium-response/</link>
					<comments>https://www.gatewaypsychiatric.com/predicting-lithium-response/#respond</comments>
		
		<dc:creator><![CDATA[Peter Forster]]></dc:creator>
		<pubDate>Tue, 19 Nov 2019 02:17:19 +0000</pubDate>
				<category><![CDATA[Bipolar Treatment]]></category>
		<category><![CDATA[bipolar]]></category>
		<category><![CDATA[lithium]]></category>
		<category><![CDATA[treatment response]]></category>
		<category><![CDATA[treatment selection]]></category>
		<guid isPermaLink="false">https://www.gatewaypsychiatric.com/?p=15909</guid>

					<description><![CDATA[<p>Lithium is usually considered the most effective treatment for bipolar disorder. However, at least 30% of lithium-treated patients do not have a clinically significant response; and only 30% have a long-lasting full response. Since close laboratory monitoring is required, and adverse effects are not uncommon, identifying predictors of lithium response is highly desirable. In this largest-ever study of lithium recipients ... </p>
<div><a href="https://www.gatewaypsychiatric.com/predicting-lithium-response/" class="more-link">Read More</a></div>
<p>The post <a href="https://www.gatewaypsychiatric.com/predicting-lithium-response/">Predicting Lithium Response</a> appeared first on <a href="https://www.gatewaypsychiatric.com">Gateway Psychiatric</a>.</p>
]]></description>
		
					<wfw:commentRss>https://www.gatewaypsychiatric.com/predicting-lithium-response/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">15909</post-id>	</item>
		<item>
		<title>Genetic Tests for Antidepressants &#8211; CNS Dose</title>
		<link>https://www.gatewaypsychiatric.com/genetic-tests-for-antidepressants-cns-dose/</link>
					<comments>https://www.gatewaypsychiatric.com/genetic-tests-for-antidepressants-cns-dose/#respond</comments>
		
		<dc:creator><![CDATA[Peter Forster]]></dc:creator>
		<pubDate>Mon, 10 Jul 2017 02:25:56 +0000</pubDate>
				<category><![CDATA[Best Practices]]></category>
		<category><![CDATA[GPS Update]]></category>
		<category><![CDATA[Major Depression]]></category>
		<category><![CDATA[Testing]]></category>
		<category><![CDATA[Treatments of Depression]]></category>
		<category><![CDATA[antidepressant]]></category>
		<category><![CDATA[cns dose]]></category>
		<category><![CDATA[genetic testing]]></category>
		<category><![CDATA[gps update]]></category>
		<category><![CDATA[treatment selection]]></category>
		<guid isPermaLink="false">https://www.gatewaypsychiatric.com/?p=14344</guid>

					<description><![CDATA[<p>About a year ago we reviewed the data on the use of genetic tests for antidepressants as well as other medications and identified three pharmacogenetic panels that seem to have research support: Genecept by Genomind, Genesight, and CNS Dose. Of these three we have been using Genecept and Genesight with some success but now we are happy to add to ... </p>
<div><a href="https://www.gatewaypsychiatric.com/genetic-tests-for-antidepressants-cns-dose/" class="more-link">Read More</a></div>
<p>The post <a href="https://www.gatewaypsychiatric.com/genetic-tests-for-antidepressants-cns-dose/">Genetic Tests for Antidepressants &#8211; CNS Dose</a> appeared first on <a href="https://www.gatewaypsychiatric.com">Gateway Psychiatric</a>.</p>
]]></description>
		
					<wfw:commentRss>https://www.gatewaypsychiatric.com/genetic-tests-for-antidepressants-cns-dose/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">14344</post-id>	</item>
		<item>
		<title>Efficacy or Effectiveness</title>
		<link>https://www.gatewaypsychiatric.com/efficacy-or-effectiveness/</link>
		
		<dc:creator><![CDATA[Peter Forster]]></dc:creator>
		<pubDate>Sun, 26 Mar 2017 20:13:07 +0000</pubDate>
				<category><![CDATA[Major Depression]]></category>
		<category><![CDATA[Treatments of Depression]]></category>
		<category><![CDATA[antidepressants]]></category>
		<category><![CDATA[cognitive behavioral therapy]]></category>
		<category><![CDATA[matching]]></category>
		<category><![CDATA[outcomes]]></category>
		<category><![CDATA[pharmacotherapy]]></category>
		<category><![CDATA[preferences]]></category>
		<category><![CDATA[treatment selection]]></category>
		<guid isPermaLink="false">https://www.gatewaypsychiatric.com/?p=12601</guid>

					<description><![CDATA[<p>What is the difference between efficacy and effectiveness? We tend to use these terms interchangeably in our posts on this site, but the two are different and the difference can be important. Efficacy refers to the power of a treatment to achieve a given outcome assuming that the patient is perfectly compliant and completes the treatment. Effectiveness addresses the more ... </p>
<div><a href="https://www.gatewaypsychiatric.com/efficacy-or-effectiveness/" class="more-link">Read More</a></div>
<p>The post <a href="https://www.gatewaypsychiatric.com/efficacy-or-effectiveness/">Efficacy or Effectiveness</a> appeared first on <a href="https://www.gatewaypsychiatric.com">Gateway Psychiatric</a>.</p>
]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">12601</post-id>	</item>
		<item>
		<title>Antidepressant Selection Based on Symptom Clusters</title>
		<link>https://www.gatewaypsychiatric.com/antidepressant-selection-based-symptom-clusters/</link>
		
		<dc:creator><![CDATA[Peter Forster]]></dc:creator>
		<pubDate>Fri, 03 Mar 2017 15:32:48 +0000</pubDate>
				<category><![CDATA[Best Practices]]></category>
		<category><![CDATA[Major Depression]]></category>
		<category><![CDATA[Testing]]></category>
		<category><![CDATA[antidepressant]]></category>
		<category><![CDATA[treatment of depression]]></category>
		<category><![CDATA[treatment selection]]></category>
		<guid isPermaLink="false">https://www.gatewaypsychiatric.com/?p=12483</guid>

					<description><![CDATA[<p>Can we do a better job of antidepressant selection based on symptom clusters, analyzed using machine learning techniques? Perhaps so. And if so we will avoid a great deal of unnecessary suffering as people try one medication after another until the find the right medication or combination of medications to treat their depression. That is the premise behind an ambitious ... </p>
<div><a href="https://www.gatewaypsychiatric.com/antidepressant-selection-based-symptom-clusters/" class="more-link">Read More</a></div>
<p>The post <a href="https://www.gatewaypsychiatric.com/antidepressant-selection-based-symptom-clusters/">Antidepressant Selection Based on Symptom Clusters</a> appeared first on <a href="https://www.gatewaypsychiatric.com">Gateway Psychiatric</a>.</p>
]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">12483</post-id>	</item>
		<item>
		<title>Depression and Inflammation: Treatment Options</title>
		<link>https://www.gatewaypsychiatric.com/depression-inflammation-treatment-options/</link>
		
		<dc:creator><![CDATA[Peter Forster]]></dc:creator>
		<pubDate>Sat, 08 Oct 2016 21:22:33 +0000</pubDate>
				<category><![CDATA[Major Depression]]></category>
		<category><![CDATA[Physical Conditions and Health]]></category>
		<category><![CDATA[Treatments of Depression]]></category>
		<category><![CDATA[celecoxib]]></category>
		<category><![CDATA[chronic depression]]></category>
		<category><![CDATA[depression]]></category>
		<category><![CDATA[fish oil]]></category>
		<category><![CDATA[inflammation]]></category>
		<category><![CDATA[treatment]]></category>
		<category><![CDATA[treatment of depression]]></category>
		<category><![CDATA[treatment selection]]></category>
		<guid isPermaLink="false">https://www.gatewaypsychiatric.com/?p=11949</guid>

					<description><![CDATA[<p>A host of conditions have been associated with mild to moderate levels of inflammation in the body. Depression is one of these. Elsewhere in this blog we have discussed the relationship between&#160;depression and inflammation, evidence that treatment with an antidepressant (escitalopram) reduces inflammation in depression, and talked about&#160;how exercise prevents depression. We have also noted that elevated levels of inflammation&#160;(simple ... </p>
<div><a href="https://www.gatewaypsychiatric.com/depression-inflammation-treatment-options/" class="more-link">Read More</a></div>
<p>The post <a href="https://www.gatewaypsychiatric.com/depression-inflammation-treatment-options/">Depression and Inflammation: Treatment Options</a> appeared first on <a href="https://www.gatewaypsychiatric.com">Gateway Psychiatric</a>.</p>
]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">11949</post-id>	</item>
		<item>
		<title>Mania and Depression Sequence</title>
		<link>https://www.gatewaypsychiatric.com/mania-and-depression-sequence/</link>
		
		<dc:creator><![CDATA[Peter Forster]]></dc:creator>
		<pubDate>Sun, 15 May 2016 13:03:05 +0000</pubDate>
				<category><![CDATA[Best Practices]]></category>
		<category><![CDATA[Bipolar Treatment]]></category>
		<category><![CDATA[bipolar]]></category>
		<category><![CDATA[dmi]]></category>
		<category><![CDATA[lamotrigine]]></category>
		<category><![CDATA[lithium]]></category>
		<category><![CDATA[mdi]]></category>
		<category><![CDATA[mood sequence]]></category>
		<category><![CDATA[treatment]]></category>
		<category><![CDATA[treatment selection]]></category>
		<guid isPermaLink="false">https://www.gatewaypsychiatric.com/?p=10768</guid>

					<description><![CDATA[<p>One of the key features of bipolar disorder that, in our experience, is most useful in predicting treatment response is the usual sequence of manic (or hypomanic) and depressive episodes. For years we have used the mnemonics MDI and DMI as ways of categorizing patients&#8217; course. But we could not find the reference to that idea. We are indebted to ... </p>
<div><a href="https://www.gatewaypsychiatric.com/mania-and-depression-sequence/" class="more-link">Read More</a></div>
<p>The post <a href="https://www.gatewaypsychiatric.com/mania-and-depression-sequence/">Mania and Depression Sequence</a> appeared first on <a href="https://www.gatewaypsychiatric.com">Gateway Psychiatric</a>.</p>
]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">10768</post-id>	</item>
	</channel>
</rss>
